Pharmaceutical Representative Training

FEBRUARY 4, 2021

While the sales force is still a crucial part of any pharmaceutical company, the demand for Medical Affairs teams continue to rise. How are sales reps and Medical Science Liaisons (MSLs) the same? Ways Pharma reps and MSLs are different: Typically, an MSL holds a doctorate degree, whether it be a PhD, MD, or PharmD.

Medical science 52

Medical science Pharmaceutical Sales Sales Medical 52

Pharmaceutical Technology

NOVEMBER 2, 2022

Acting as a go-between for pharma and physicians, medical science liaisons (MSLs) are responsible for communicating necessary information about new medicines to healthcare professionals and key opinion leaders (KOLs). As with many aspects of the medical world, they are now shifting online. A fresh approach.

Medical 52

Medical Medicine Pharma Networking 52

PM360

SEPTEMBER 15, 2022

The pandemic has also disrupted how HCPs interact with their colleagues and pharma in sharing information. Where once pharma relied on reps and medical science liaisons (MSLs) to engage clinicians, many digital interactions, such as video conferencing, have replaced the need for in-person meetings.

Education 52

Education Media Medical Physicians 52

PM360

AUGUST 29, 2022

While no one event would have been enough to trigger consideration of the syndrome under study, when combined with an EHR query the HCP was able to find and more formally assess patients with a confusing array of health issues. Advance Medical Science.

Electronics 97

Electronics Patients Medical Healthcare 97

Celeritas

OCTOBER 23, 2022

An MSL is a medically specialized representative for pharmaceutical companies. By outlining the product specifications, advising, and educating, they act as a bridge between pharma companies and their clients. This means that during the Q&A session, you may face a myriad of intricate medical, functional, or operational questions.

Medical science 40

Medical science Medical Specialization Doctors 40

Medgadget

MARCH 22, 2023

Thanks to support from Biomed Israel , the leading international Life Science and HealthTech conference in Israel (see more below about the upcoming event), we had a chance to learn about Imagene’s technology from Dean Bitan, CEO and Co-Founder of the company. Eventually the technology should be agnostic to any tissue type.

Patients 79

Patients Medical science Leads Medical 79